Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jing Shi
Institutions:
Xinjiang Medical University,
Tumor Hospital of Xinjiang Medical University
Observed institutions:
Xinjiang Medical University,
Tumor Hospital of Xinjiang Medical University
ORCID:
0009-0009-9498-5077
Observed ORCID:
0009-0009-9498-5077
OpenAlex ID:
A5111296831
Interstitial lung disease with antibody–drug conjugates: a real-world pharmacovigilance study based on the FAERS database during the period 2014–2023
2024
·
Jing Shi
, Xinya Liu
, et al.
·
Therapeutic Advances in Respiratory Disease
·
27
CAR-T therapy pulmonary adverse event profile: a pharmacovigilance study based on FAERS database (2017–2023)
2024
·
Jing Shi
, Xinya Liu
, et al.
·
Frontiers in Pharmacology
·
10
PDF
Roles of myeloperoxidase and the AMPK/PI3K/AKT/eNOS pathway in osimertinib-induced cardiotoxicity: multilevel evidence from disequilibrium analysis, network pharmacology, mendelian randomization, and animal experiments
2026
·
Jing Shi
, Xinya Liu
, et al.
·
Frontiers in Pharmacology
PDF
Bioinformatics and network pharmacology to explore Huangqi Guizhi Wuwu Decoction in regulating mitophagy to ameliorate doxorubicin-induced cardiotoxicity the potential mechanism
2026
·
Jian Yu
, Jiangtao Wang
, et al.
·
Medicine
Combining multi-omics analysis methods to identify biomarkers for mitophagy involved in immune checkpoint inhibitors-related myocarditis
2026
·
Jian Yu
, Jiangtao Wang
, et al.
·
Frontiers in Immunology
PDF
Author response for "Interstitial lung disease with antibody–drug conjugates: a real-world pharmacovigilance study based on the FAERS database during the period 2014–2023"
2024
·
Jing Shi
, Xinya Liu
, et al.
·
Publons reviews and discussion
Show more works
View as search
Works count:
6
Citation count:
37
H-index:
2
I10-index:
2
Year
Topic
Type